Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 24618442)

1.

Tensegrity model hypothesis: may this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection?

Fiorino S, Bacchi-Reggiani L, Pontoriero L, Gallo C, Chili E, Masetti M, Zanini N, Grondona A, Silvestri T, Deleonardi G, Fornelli A, Bondi A, de Biase D, Baccarini P, Tallini G, Tropeano A, Quartuccio V, Cuppini A, Castellani G, Jovine E.

JOP. 2014 Mar 10;15(2):151-64. doi: 10.6092/1590-8577/2099. Review.

2.

HBV- and HCV-related infections and risk of pancreatic cancer.

Fiorino S, Cuppini A, Castellani G, Bacchi-Reggiani ML, Jovine E.

JOP. 2013 Nov 10;14(6):603-9. doi: 10.6092/1590-8577/1948. Review.

3.

Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis.

Fiorino S, Chili E, Bacchi-Reggiani L, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Magrini E, Zanini N, Cuppini A, Nardi R, Jovine E.

Pancreatology. 2013 Mar-Apr;13(2):147-60. doi: 10.1016/j.pan.2013.01.005. Epub 2013 Jan 28. Review.

PMID:
23561973
4.

Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies.

Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD.

World J Gastroenterol. 2013 Jul 14;19(26):4234-41. doi: 10.3748/wjg.v19.i26.4234. Review.

6.

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.

Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T.

Gut. 1999 Aug;45(2):284-8.

7.

Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.

Fiorino S, Bacchi-Reggiani L, Sabbatani S, Grizzi F, di Tommaso L, Masetti M, Fornelli A, Bondi A, de Biase D, Visani M, Cuppini A, Jovine E, Pession A.

Br J Nutr. 2014 Dec 14;112(11):1751-68. doi: 10.1017/S0007114514002839. Epub 2014 Oct 17. Review.

PMID:
25325563
8.

Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma.

He D, Liu ZP, Honda M, Kaneko S, Chen L.

J Mol Cell Biol. 2012 Jun;4(3):140-52. doi: 10.1093/jmcb/mjs011. Epub 2012 Mar 31.

9.

Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.

Coppola N, Pisapia R, Tonziello G, Martini S, Imparato M, Piai G, Stanzione M, Sagnelli C, Filippini P, Piccinino F, Sagnelli E.

Antivir Ther. 2008;13(2):307-18.

PMID:
18505182
10.
11.
12.

Hepatitis B and C virus-related carcinogenesis.

Fung J, Lai CL, Yuen MF.

Clin Microbiol Infect. 2009 Nov;15(11):964-70. doi: 10.1111/j.1469-0691.2009.03035.x. Review.

13.

Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.

Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, Das BC.

J Gastroenterol Hepatol. 2001 Jun;16(6):666-73.

PMID:
11422620
14.

Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma.

Fiorino S, Lorenzini S, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Chili E, Del Prete P, Bacchi-Reggiani L, Cuppini A, Jovine E.

Med Hypotheses. 2012 Nov;79(5):678-97. doi: 10.1016/j.mehy.2012.08.008. Epub 2012 Sep 5.

PMID:
22959312
15.

Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses.

Guptan RC, Thakur V, Raina V, Sarin SK.

J Gastroenterol Hepatol. 1999 Sep;14(9):893-8.

PMID:
10535471
16.

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.

Loras C, Gisbert JP, Mínguez M, Merino O, Bujanda L, Saro C, Domenech E, Barrio J, Andreu M, Ordás I, Vida L, Bastida G, González-Huix F, Piqueras M, Ginard D, Calvet X, Gutiérrez A, Abad A, Torres M, Panés J, Chaparro M, Pascual I, Rodriguez-Carballeira M, Fernández-Bañares F, Viver JM, Esteve M; REPENTINA study; GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group.

Gut. 2010 Oct;59(10):1340-6. doi: 10.1136/gut.2010.208413. Epub 2010 Jun 24.

PMID:
20577000
17.

Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis.

Xing S, Li ZW, Tian YF, Zhang LM, Li MQ, Zhou P.

Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):575-83.

18.

Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.

Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.

J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.

PMID:
19596477
19.
20.

Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy.

Saitta C, Pontisso P, Brunetto MR, Fargion S, Gaeta GB, Niro GA, Picciotto A, Smedile A, Squadrito G, Raimondo G.

Antivir Ther. 2006;11(7):931-4.

PMID:
17302256
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk